CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
18 hedge funds and large institutions have $10.4M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.04M | |
| 2 | +$54.1K | |
| 3 | +$24.4K | |
| 4 |
LPL Financial
San Diego,
California
|
+$13.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10K |
Top Sellers
| 1 | -$635K | |
| 2 | -$243K | |
| 3 | -$112K | |
| 4 |
Citigroup
New York
|
-$45.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36.4K |